The Unfulfilled Promise of Mitochondrial Replacement Therapy
A critical review in Human Reproduction Update re-examines the clinical reality of mitochondrial replacement therapies (MRTs), advanced techniques like pronuclear transfer and maternal spindle transfer designed to prevent the inheritance of debilitating mitochondrial DNA diseases. While hailed as a groundbreaking strategy in reproductive medicine and assisted reproductive technology to allow women with pathogenic mutations to have genetically related, healthy children, emerging data raises significant questions about the reliability of these methods for definitive disease prevention. The article underscores a pressing need to evaluate the long-term efficacy and safety of these complex infertility and prenatal care interventions, balancing their promise against potential pitfalls in fetal development.
Study Significance: For specialists in reproductive endocrinology and infertility, this analysis signals a crucial moment for clinical caution and informed patient counseling. It compels the field to prioritize robust, long-term outcome studies before integrating MRTs into standard practice for preventing transmission of mitochondrial disorders, ensuring ethical and evidence-based advancement in high-risk pregnancy management.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
